PMID- 9030794 OWN - NLM STAT- MEDLINE DCOM- 19970507 LR - 20190512 IS - 1010-7940 (Print) IS - 1010-7940 (Linking) VI - 11 IP - 1 DP - 1997 Jan TI - Long-term relative survival after primary heart valve replacement. PG - 81-91 AB - OBJECTIVE: Determination of the optimal timing of primary heart valve replacement is an important issue. The present paper provides a synopsis over early and late survival after primary heart valve replacement, including an evaluation of the excess mortality among heart valve replacement patients compared with the general population. METHODS: Survival was analyzed in 2365 patients (1568 without and 797 with concomitant coronary artery bypass grafting (CABG)) who underwent their first heart valve replacement. Observed survival was related to that expected among persons from the general Swedish population stratified by age, sex, and 5-year calendar period, to calculate the relative survival and estimate the disease-specific survival. RESULTS: Early mortality (death within 30 days after surgery) was 5.9% after aortic valve replacement, 10.4% after mitral valve replacement and 10.6% after combined aortic and mitral valve replacement. Relative survival rates (excluding early deaths) were 84% 10 years after aortic, 68.5% after mitral and 80.9% after both aortic and mitral valve replacement. A multivariate model based on observed survival rates was produced for each group, using the Cox proportional hazards model. Concomitant CABG, advanced New York Heart Association (NYHA) class, preoperative atrial fibrillation, pure aortic regurgitation and higher age increased the late observed survival after aortic valve replacement. NYHA class was the only factor independently related to observed late deaths after mitral valve replacement, and mitral insufficiency the only corresponding factor after both aortic and mitral valve surgery. CONCLUSION: The use of relative survival rates tended to modify the difference between subgroups compared with observed survival rates. Relative survival rates reduced the effect of concomitant CABG on survival, but enhanced for example the effect of aortic regurgitation. In patients > or = 70 years of age and patients submitted to aortic or mitral valve replacement with mild or no symptoms, the survival rate was similar for many years to that in the Swedish population at large. FAU - Stahle, E AU - Stahle E AD - Department of Thoracic and Cardiovascular Surgery, University Hospital, Uppsala, Sweden. FAU - Kvidal, P AU - Kvidal P FAU - Nystrom, S O AU - Nystrom SO FAU - Bergstrom, R AU - Bergstrom R LA - eng PT - Comparative Study PT - Journal Article PL - Germany TA - Eur J Cardiothorac Surg JT - European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery JID - 8804069 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Aortic Valve/surgery MH - Bioprosthesis/*mortality MH - Combined Modality Therapy MH - Coronary Artery Bypass/mortality MH - Coronary Disease/mortality/surgery MH - Female MH - Follow-Up Studies MH - Heart Valve Diseases/mortality/*surgery MH - Heart Valve Prosthesis/*mortality MH - Humans MH - Male MH - Middle Aged MH - Mitral Valve/surgery MH - Postoperative Complications/*mortality MH - Proportional Hazards Models MH - Prosthesis Design MH - Registries/statistics & numerical data MH - Survival Analysis MH - Sweden/epidemiology MH - Treatment Outcome EDAT- 1997/01/01 00:00 MHDA- 1997/01/01 00:01 CRDT- 1997/01/01 00:00 PHST- 1997/01/01 00:00 [pubmed] PHST- 1997/01/01 00:01 [medline] PHST- 1997/01/01 00:00 [entrez] AID - S1010794096010251 [pii] AID - 10.1016/s1010-7940(96)01025-1 [doi] PST - ppublish SO - Eur J Cardiothorac Surg. 1997 Jan;11(1):81-91. doi: 10.1016/s1010-7940(96)01025-1.